ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Community Oncology Program Proves Technology Transfer Can Work; Survival Improvement Shown

March 21, 1980

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

Barney Lepovetsky Dead At 64

April 6, 1990

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002